Screener
Artiva Biotherapeutics, Inc. ARTV Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| Line item | AS OF / JUNE 30,2026 | AS OF / DECEMBER 31,2025 |
|---|---|---|
| Short-term investments | 47,940 | 81,307 |
| Other receivables (including related party amounts of $0 and $61, respectively) | 141 | 67 |
| Prepaid expenses and other current assets | 2,741 | 4,591 |
| Total current assets | 352,276 | 112,666 |
| Restricted cash | 461 | 461 |
| Property and equipment, net | 5,671 | 6,618 |
| Operating lease right-of-use assets | 9,236 | 10,525 |
| Financing lease right-of-use asset | 180 | 212 |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s total current assets?
- Artiva Biotherapeutics, Inc. (ARTV) reported total current assets of $352.28M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s total current assets changed year-over-year?
- Artiva Biotherapeutics, Inc.'s total current assets increased by 136.3% year-over-year, from $149.07M to $352.28M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s total current assets?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s total current assets has grown at a 18.8% compound annual growth rate (CAGR), from $79.82M to $112.67M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Artiva Biotherapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude